Literature DB >> 22866986

Processing speed and executive abilities in children with phenylketonuria.

Alicia L Janos1, Dorothy K Grange, Robert D Steiner, Desirée A White.   

Abstract

OBJECTIVE: Phenylketonuria (PKU) is a hereditary metabolic disorder that often results in neuropsychological impairment, even in individuals treated early and continuously. This study was conducted to examine processing speed, variability in processing speed, and the relationship between processing speed variables and executive abilities in children with early and continuously treated PKU.
METHOD: Participants were 42 children with PKU and 81 typically developing children from 7 to 18 years of age. Children completed 3 computerized reaction time (RT) tasks (simple RT, go/no-go, stimulus-response compatibility) and 7 tasks assessing executive abilities (working memory, inhibitory control, strategic processing).
RESULTS: Performance of children with PKU was significantly slower and more variable than that of controls across the 3 tasks administered. When age was considered, it was shown that processing speed improved with age to a comparable degree for both groups. Variability in processing speed, however, decreased more with age for the PKU than control group, reflecting the fact that variability in younger, but not older, children with PKU was greater than that of controls. With regard to executive abilities, processing speed and variability contributed to performance on most, but not all, executive tasks; and after controlling for processing speed and variability, executive impairments were still identified in working memory and inhibitory control (not strategic processing).
CONCLUSIONS: These findings indicate that information processing is slower and less efficient in children with PKU. In addition, processing speed and variability contribute to some, but not all, of the impairments in executive abilities observed in children with PKU. (c) 2012 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22866986      PMCID: PMC3526340          DOI: 10.1037/a0029419

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  41 in total

Review 1.  Chemical neuromodulation of frontal-executive functions in humans and other animals.

Authors:  T W Robbins
Journal:  Exp Brain Res       Date:  2000-07       Impact factor: 1.972

2.  Influence of processing speed on adult age differences in working memory.

Authors:  T A Salthouse
Journal:  Acta Psychol (Amst)       Date:  1992-03

Review 3.  The processing-speed theory of adult age differences in cognition.

Authors:  T A Salthouse
Journal:  Psychol Rev       Date:  1996-07       Impact factor: 8.934

4.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood.

Authors:  A Pfefferbaum; D H Mathalon; E V Sullivan; J M Rawles; R B Zipursky; K O Lim
Journal:  Arch Neurol       Date:  1994-09

5.  Executive functioning, memory, and learning in phenylketonuria.

Authors:  Shelley Channon; Elaine German; Cristina Cassina; Philip Lee
Journal:  Neuropsychology       Date:  2004-10       Impact factor: 3.295

6.  Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities.

Authors:  Peter J Anderson; Stephen J Wood; Dorothy E Francis; Lee Coleman; Linda Warwick; Sue Casanelia; Vicki A Anderson; Avihu Boneh
Journal:  Dev Med Child Neurol       Date:  2004-04       Impact factor: 5.449

7.  Continuous performance test performance in a normative epidemiological sample.

Authors:  C Keith Conners; Jeffery N Epstein; Adrian Angold; John Klaric
Journal:  J Abnorm Child Psychol       Date:  2003-10

8.  Blood phenylalanine control in adolescents with phenylketonuria.

Authors:  John H Walter; Fiona J White
Journal:  Int J Adolesc Med Health       Date:  2004 Jan-Mar

9.  Lowering brain phenylalanine levels by giving other large neutral amino acids. A new experimental therapeutic approach to phenylketonuria.

Authors:  A E Andersen; L Avins
Journal:  Arch Neurol       Date:  1976-10

10.  Executive dysfunction in treated phenylketonuric patients.

Authors:  Bahare Azadi; Arshia Seddigh; Mehdi Tehrani-Doost; Javad Alaghband-Rad; Mahmoud Reza Ashrafi
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-16       Impact factor: 4.785

View more
  10 in total

1.  The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.

Authors:  A Bartus; F Palasti; E Juhasz; E Kiss; E Simonova; Cs Sumanszki; P Reismann
Journal:  Metab Brain Dis       Date:  2018-06-12       Impact factor: 3.584

2.  Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria.

Authors:  Zoë W Hawks; Michael J Strube; Neco X Johnson; Dorothy K Grange; Desirée A White
Journal:  Dev Neuropsychol       Date:  2018-02-12       Impact factor: 2.253

3.  Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models-a cohort study in 180 patients.

Authors:  Sven F Garbade; Cheryl R Greenberg; Mübeccel Demirkol; Gülden Gökçay; Antonia Ribes; Jaume Campistol; Alberto B Burlina; Peter Burgard; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2014-05-09       Impact factor: 4.982

4.  Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.

Authors:  Anna Hood; Jerrel Rutlin; Joshua S Shimony; Dorothy K Grange; Desiree A White
Journal:  JIMD Rep       Date:  2016-07-22

5.  White matter integrity and executive abilities in individuals with phenylketonuria.

Authors:  Jo Ann V Antenor-Dorsey; Tamara Hershey; Jerrel Rutlin; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Desirée A White
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

6.  Relationship between age and white matter integrity in children with phenylketonuria.

Authors:  Erika Wesonga; Joshua S Shimony; Jerrel Rutlin; Dorothy K Grange; Desiree A White
Journal:  Mol Genet Metab Rep       Date:  2016-04-08

7.  White matter microstructural damage in early treated phenylketonuric patients.

Authors:  María Julieta González; Mónica Rebollo Polo; Pablo Ripollés; Rosa Gassió; Aída Ormazabal; Cristina Sierra; Roser Colomé Roura; Rafael Artuch; Jaume Campistol
Journal:  Orphanet J Rare Dis       Date:  2018-10-26       Impact factor: 4.123

8.  White and gray matter brain development in children and young adults with phenylketonuria.

Authors:  Zoë Hawks; Anna M Hood; Dov B Lerman-Sinkoff; Joshua S Shimony; Jerrel Rutlin; Daniel Lagoni; Dorothy K Grange; Desirée A White
Journal:  Neuroimage Clin       Date:  2019-07-02       Impact factor: 4.881

9.  Executive functioning, adaptive skills, emotional and behavioral profile: A comparison between autism spectrum disorder and phenylketonuria.

Authors:  Barbara Trimarco; Filippo Manti; Francesca Nardecchia; Sergio Melogno; Mara Testa; Giovanni Meledandri; Claudia Carducci; Roberta Penge; Vincenzo Leuzzi
Journal:  Mol Genet Metab Rep       Date:  2020-03-09

10.  Cognitive Outcomes and Relationships with Phenylalanine in Phenylketonuria: A Comparison between Italian and English Adult Samples.

Authors:  Cristina Romani; Filippo Manti; Francesca Nardecchia; Federica Valentini; Nicoletta Fallarino; Claudia Carducci; Sabrina De Leo; Anita MacDonald; Liana Palermo; Vincenzo Leuzzi
Journal:  Nutrients       Date:  2020-10-03       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.